Intriguingly, these wild-type p53-induced responses are in line with its tumor suppressor role, while its p53 mutant counterpart generally exerts an opposite response to sustain its oncogenic role in cancers, such as the pro-oxidant effect or reprogramming of energy metabolism and chemoresistance, which are briefly discussed in the following sections. The gene discussed is TP53; the disease is neoplasm.